Several of these processes such as axon guidance, netrin signalling and adhesion signalling, are common with the enriched pathways in Pcyt2 + /- without PEA treatment, but do not include the same genes, suggesting an influence of PEA on these pathways that may specifically contribute to NASH reversion. Here, PCYT2 is linked to metabolic dysfunction-associated steatohepatitis.